Research

SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of COVID-19

COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management

A Randomized Trial of Convalescent Plasma in COVID-19 Severe Pneumonia

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19

• Telemedicine consultations can aid effective epilepsy care, even for first visits.

Caution is warranted with the use of antiseizure medications in the context of COVID-19 illness.

This neurology update focuses on mental well-being of people with epilepsy and their caregivers during the COVID-19 pandemic.

This is an interesting work elucidating for the first time a role for ataxin-1 (ATXN1) mutation, traditionally linked to spinocerebellar ataxia-type 1 (SCA1), in the pathogenesis of Experimental Autoimmune Encephalomyelitis (EAE), the rodent model for Multiple Sclerosis (MS)

The International Restless Legs Syndrome Study Group task force found sufficient evidence to formulate diagnostic criteria for pediatric clinical entity designated “restless sleep disorder”.